Compare Heima (HEI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heima vs Enzyme — how do they compare? Heima trades at Rp2,239 (market cap Rp180,34M, Rp185,16M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Heima is the larger of the two by market cap, and Heima's supply is capped (81,5M / 100M HEI (82%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Heima for 11 Days and Enzyme for 29 Days on average.
| HEI | MLN | |
|---|---|---|
Market Cap | Rp180,34M | Rp134,13M |
Volume (24h) | Rp185,16M | Rp104,56M |
Circulating Supply | 81,5M / 100M HEI (82%) | 3,3M MLN |
Typical Hold Time | 11 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HEI (Heima) is currently trading at Rp2,198.904 with a market cap of Rp179.25 million, showing bullish technical signals despite mixed moving averages. The token has a circulating supply of 81.5 million HEI (82% of max supply) with an average hold time of 11 days. Technical indicators show strong momentum with RSI_6 at 21.06 (oversold) and ADX readings above 66 indicating strong trend strength. Support levels are established at Rp1,831 (S3) to Rp2,087 (S1), with resistance at Rp2,343 (R1) to Rp2,600 (R3).
Overall outlook is cautiously optimistic with bullish oscillators supporting upward momentum, though bearish moving averages suggest near-term consolidation. Key opportunities include potential breakout above Rp2,241 pivot point, while risks include low liquidity and typical crypto volatility. Investors should monitor volume patterns and network adoption metrics for confirmation of sustained momentum.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heima
As an evolution of the Litentry Network, the Heima Network was developed focusing on decentralized identity and privacy solutions. Building on this foundation, Heima expanded its scope to address cross-chain asset management and multi-chain interoperability.
Read more on HEI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
